Skip to main content
. 2010 Jan 19;89(4):331–339. doi: 10.1007/s00277-009-0895-3

Table 2.

Clinicopathologic characteristics and outcome of 110 Asian patients with T-large granular lymphocyte leukemia

Parameters Patients
Reported Asiana Current series p value
Sex
 Male 43 14
 Female 45 8 0.215
Age (mean ± standard error of the mean, years) 58.3 ± 1.7 52.3 ± 3.2 0.118
Hemoglobin
 Mean ± standard error of the mean (g/dL) 9.0 ± 0.4 8.1 ± 0.7 0.236
 Low (<10 g/dL) 49 17 0.064
Neutrophil count
 Mean ± standard error of the mean (×109/L) 3.4 ± 0.3 4.8 ± 1.0 0.179
 Low (<1.5 × 109/L) 25 8 0.466
Large granular lymphocyte count
 Mean ± standard error of the mean (×109/L) 8.0 ± 0.8 3.4 ± 0.7 <0.001
 High (>2 × 109/L) 77 14 0.008
Platelet count
 Mean ± standard error of the mean (×109/L) 265 ± 14 204 ± 28 0.436
 Low (<150 × 109/L) 13 5 0.367
Hepatomegaly
 Present 4 5
 Absent 84 17 0.005
Splenomegaly
 Present 8 8
 Absent 80 14 0.001
Pure red cell aplasia
 Present 37 15
 Absent 51 7 0.028
Rheumatoid arthritis
 Present 4 0
 Absent 84 22 0.308
Autoimmune phenomena
 Autoimmune hemolysis 1 0
 Autoimmune thyroiditis 1 0
 Bechet disease 1 0
 Aplastic anemia 1 0
 Immune thrombocytopenia purpura 0 1
Other associated conditions
 Infection as presentation 3 0
 Acute myeloid leukemia 1 0
 Autologous hematopoietic stem cell transplantation 1 0
 Renal allografting 1 0
 Parvovirus B19 infection 1 0
 Allogeneic hematopoietic stem cell transplantation 0 1
T-cell receptor gene rearrangement
 Clonal rearrangement 70 20
 Non-clonal rearrangement 6 2
 Not reported 11
Treatment outcome
 Cyclophosphamide-induced remission 15/20 0/6
 Cyclosporine-induced remission 4/5 4/14
 Fludarabine-induced remission 0 8/13
 Remission induced by other agents 0 0
 Spontaneous remission 4 0

aThe results do not always add up to the total number of patients because some data may be missing from the articles reviewed